CARVER KYLE (Chief Financial Officer) purchased 1.7% of their position (1K shares) of EVOMMUNE, INC. on the open market
Open‑market purchase worth $13.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/10/2026ACC: 0001757072-26-000007
Officer· Chief Financial Officer
Since Nov 2025
+1K
Net shares
Net buyer
$13.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$13.26
Trade value
$13.26K
% of position
1.7%
7/8/2026
59.34K→60.34K
Total
Net shares
+1K
Net value
$13.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | P · Purchase | +1K | $13.26 | $13.26K | 1.7% | 59.34K | 60.34K |
| Total | +1K | $13.26K | ||||||
Derivative Transactions0
No derivative transactions reported